Biotalys NV
Brussels Stock Exchange BTLS.BR
Biotalys NV EPS (Diluted) for the year ending December 31, 2023: USD -0.72
Biotalys NV EPS (Diluted) is USD -0.72 for the year ending December 31, 2023, a 9.39% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
-
Biotalys NV EPS (Diluted) for the year ending December 31, 2022 was USD -0.79, a 36.77% change year over year.
-
Biotalys NV EPS (Diluted) for the year ending December 31, 2021 was USD -1.25, a -184.74% change year over year.
-
Biotalys NV EPS (Diluted) for the year ending December 31, 2020 was USD -0.44, a -50.72% change year over year.
-
Biotalys NV EPS (Diluted) for the year ending December 31, 2019 was USD -0.29.
Key data
| Date | EPS (Diluted) | Shares (Diluted, Weighted) | Shares (Basic, Weighted) | Revenue |
|---|
Market news
Loading...
Brussels Stock Exchange: BTLS.BR
| CEO | Mr. Kevin R. Helash |
| IPO Date | July 2, 2021 |
| Location | Belgium |
| Headquarters | Buchtenstraat 11 |
| Employees | 75 |
| Sector | Health Care |
| Industries | |
Description
Biotalys NV, an agricultural technology company, discovers and develops novel biological products for the protection of food and crops. It primarily develops biofungicides, bioinsecticides, and biobactericides. The company was formerly known as Agrosavfe NV. Biotalys NV was incorporated in 2013 and is headquartered in Gent, Belgium.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email